GEHC vs SIEGY: Which Is the Better Buy in 2026?
Last updated October 2026
Short answer
SIEGY is the larger of the two ($229.75B market cap): the incumbent the market prices for continued execution (20.61x forward earnings, beta 1.29). GEHC is the smaller challenger ($31.65B), cheaper on forward earnings (12.86x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
GEHC vs SIEGY: the tie-breaker metrics
Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | GEHC | SIEGY | What it tells you |
|---|---|---|---|
| Market cap | $31.65B | $229.75B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 12.86 | 20.61 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 15.99 | 25.74 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.85 | 1.29 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 35% of range | 64% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 2.86 | 3.03 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: GEHC is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how GEHC and SIEGY affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. GEHC and SIEGY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined GEHC and SIEGY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does GE HealthCare (GEHC) do?
GE HealthCare is the medical technology business spun off from the former General Electric conglomerate as an independent company. It is one of the world's largest makers of medical imaging and diagnostic equipment. Its product portfolio spans MRI, CT, X-ray, ultrasound, and molecular imaging systems, plus contrast agents and radiopharmaceuticals used in scans, patient monitoring devices, and a growing suite of healthcare software and AI tools that help clinicians interpret images and manage care. GE HealthCare makes money by selling these large imaging systems to hospitals and clinics, and importantly through recurring revenue from service contracts, maintenance, software, and consumables like contrast media. With a large installed base of equipment worldwide, the company benefits from steady demand for diagnostics, an aging global population, and the growing role of AI in radiology. Headquartered in Chicago, it serves healthcare providers across developed and emerging markets and competes among the top global medical imaging vendors.
What does Siemens AG (SIEGY) do?
Siemens AG is one of Europe's largest industrial technology companies, headquartered in Munich. It runs four main businesses: Digital Industries (factory automation hardware such as PLCs and drives, plus industrial software including Xcelerator, Teamcenter, NX and the recently acquired Altair and Dotmatics), Smart Infrastructure (electrical products, grid technology and building systems, a big beneficiary of data center and electrification spending), Mobility (rail vehicles, signaling and rail software), and a roughly 67% stake in Siemens Healthineers, the medical imaging and diagnostics company that Siemens plans to separate. Fiscal years end on September 30, and US investors typically hold the company through the SIEGY sponsored ADR, which trades over the counter in dollars rather than on a US exchange. The company employs roughly 300,000 people, sells in close to 190 countries and generates a large share of revenue outside Germany, with the US and China among its biggest markets.
GEHC vs SIEGY: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- GEHC drivers: Large installed base and recurring revenue; AI and software in imaging.
- SIEGY drivers: Electrification and data center demand at Smart Infrastructure; Industrial software and the Altair and Dotmatics deals.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: GE HealthCare sells capital equipment to hospitals, whose budgets can tighten during economic or fiscal pressure, delaying purchases. For SIEGY, siemens is cyclical at the margin: an industrial slowdown, weaker China demand or a pause in data center spending would hit orders and the premium multiple at the same time.
GEHC or SIEGY: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick GEHC if you believe its drivers more; SIEGY if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the GEHC and SIEGY guides.
GEHC vs SIEGY: the full fundamentals
GEHC. At about $70, GE HealthCare trades near 16x trailing and 13x forward earnings and about 11x EV/EBITDA, below where it stood at the start of 2026 after the shares fell about 15% year to date. Investors weigh steady diagnostics demand, recurring service revenue and AI-driven upgrades against hospital capital-spending cycles and spinoff debt. Q3 results on October 28 are expected to show EPS near $1.21; the 20-analyst mean target is about $83.
SIEGY. At a Frankfurt share price around €240, Siemens trades at roughly 21 times the midpoint of its raised fiscal 2026 EPS guidance, a premium to its own history and to many diversified industrials but below pure-play electrification and automation names such as Schneider Electric. The SIEGY ADR represents one-half of an ordinary share, so its dollar price is roughly half the euro share price converted at the current exchange rate. Full fiscal 2026 results are due in mid-November 2026. The quarterly cadence matters for ADR holders: results arrive in November, February, May and August, and the ADR typically reacts in the US session following the morning German release.
Headline figures (approximate, October 2026): GEHC shows revenue (ttm) ~$21.3 billion, revenue growth (q2 2026, yoy) ~6%, operating margin ~15%, net income (ttm) ~$2.0 billion; SIEGY shows revenue (ttm) ~€81 billion, fiscal q3 2026 orders ~€27.9 billion (book-to-bill ~1.34), order backlog ~€132 billion, fy2026 eps pre-ppa guidance ~€11.20 to €11.50.
The bottom line: GEHC vs SIEGY
GEHC and SIEGY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined GEHC and SIEGY exposure against your real portfolio. It is not an investment adviser.
Wondering how GEHC or SIEGY fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in GE HealthCare with AI
Connect the broker you already use and ask Walnut's AI how GEHC fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between GEHC and SIEGY?
+
GE HealthCare is the medical technology business spun off from the former General Electric conglomerate as an independent company. Siemens AG is one of Europe's largest industrial technology companies, headquartered in Munich. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is GEHC or SIEGY the better stock?
+
Neither is universally better. SIEGY is the larger incumbent; GEHC is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, GEHC or SIEGY?
+
On forward P/E (as of October 2026), GEHC trades at 12.86x and SIEGY at 20.61x, so GEHC is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both GEHC and SIEGY?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of GEHC vs SIEGY?
+
GEHC: GE HealthCare sells capital equipment to hospitals, whose budgets can tighten during economic or fiscal pressure, delaying purchases. It faces intense competition from Siemens Healthineers, Philips, and others, and pricing pressure in mature imaging categories. Supply chain disruptions and component shortages can affect deliveries. As a recently independent company, it carries debt from the spinoff (Yahoo shows about $10.5 billion of debt against $2.1 billion of cash) and must execute on its own strategy. Regulatory approval, reimbursement changes, and product recalls are risks in medical devices. Currency swings affect its global revenue. Margins in hardware can be modest, and growth depends on successfully expanding higher-margin software, services, and contrast media against capable, well-resourced competitors. Quarterly results have been uneven in 2026, with a Q1 EPS miss followed by a Q2 beat, and the stock is still about 15% lower year to date, so another miss could weigh on sentiment. SIEGY: Siemens is cyclical at the margin: an industrial slowdown, weaker China demand or a pause in data center spending would hit orders and the premium multiple at the same time. Software acquisitions carry integration and goodwill risk, and Mobility has a history of lumpy, lower-margin contracts. Tariffs and trade friction between the US, EU and China affect a company with factories and customers in all three. For SIEGY holders specifically, the ADR is priced in dollars but the business reports in euros, so a stronger dollar can reduce returns even if the underlying shares rise, and German withholding tax on dividends (with depositary fees) reduces the net payout. As an OTC ADR, SIEGY can also have wider spreads and thinner trading than the Frankfurt listing, and corporate actions such as the Healthineers distribution may be handled differently for ADR holders (for example sold for cash) than for ordinary shareholders. Finally, the stock has re-rated on record orders, so a quarter of slower bookings could weigh on the shares more than on the fundamentals.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell GEHC or SIEGY; figures are approximate and dated (as of October 2026). Verify current data before investing.